Catherine L. Cherry

3.6k total citations
79 papers, 2.6k citations indexed

About

Catherine L. Cherry is a scholar working on Virology, Emergency Medicine and Infectious Diseases. According to data from OpenAlex, Catherine L. Cherry has authored 79 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Virology, 33 papers in Emergency Medicine and 30 papers in Infectious Diseases. Recurrent topics in Catherine L. Cherry's work include HIV Research and Treatment (53 papers), HIV-related health complications and treatments (33 papers) and HIV/AIDS drug development and treatment (19 papers). Catherine L. Cherry is often cited by papers focused on HIV Research and Treatment (53 papers), HIV-related health complications and treatments (33 papers) and HIV/AIDS drug development and treatment (19 papers). Catherine L. Cherry collaborates with scholars based in Australia, South Africa and United States. Catherine L. Cherry's co-authors include Steve Wesselingh, Justin C. McArthur, Peter Kamerman, Antonia Wadley, Patricia Price, Katherine A. Thompson, Jennifer Hoy, Catriona McLean, Michelle E. Gahan and Luxshimi Lal and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Catherine L. Cherry

78 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine L. Cherry Australia 29 1.3k 953 924 508 488 79 2.6k
Mariana Gerschenson United States 27 736 0.6× 1.1k 1.1× 766 0.8× 268 0.5× 162 0.3× 87 2.2k
Deanna Saylor United States 19 948 0.7× 472 0.5× 562 0.6× 169 0.3× 255 0.5× 111 2.1k
Tracy Fischer United States 23 894 0.7× 287 0.3× 583 0.6× 640 1.3× 155 0.3× 53 2.5k
J. E. Bell United Kingdom 22 991 0.8× 318 0.3× 447 0.5× 170 0.3× 195 0.4× 35 2.4k
Zoë Fox United Kingdom 27 425 0.3× 156 0.2× 470 0.5× 266 0.5× 1.2k 2.5× 55 2.7k
Aylin Yilmaz Sweden 24 876 0.7× 361 0.4× 1.1k 1.2× 88 0.2× 356 0.7× 68 1.8k
Michael R. Watters United States 20 1.1k 0.9× 759 0.8× 681 0.7× 106 0.2× 78 0.2× 29 1.7k
Hong Wan United States 24 949 0.7× 309 0.3× 1.3k 1.4× 120 0.2× 47 0.1× 61 2.0k
Katrin Hahn Germany 22 253 0.2× 128 0.1× 193 0.2× 240 0.5× 308 0.6× 110 1.7k
Pasiri Sithinamsuwan Thailand 19 507 0.4× 288 0.3× 318 0.3× 114 0.2× 97 0.2× 55 1.0k

Countries citing papers authored by Catherine L. Cherry

Since Specialization
Citations

This map shows the geographic impact of Catherine L. Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine L. Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine L. Cherry more than expected).

Fields of papers citing papers by Catherine L. Cherry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine L. Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine L. Cherry. The network helps show where Catherine L. Cherry may publish in the future.

Co-authorship network of co-authors of Catherine L. Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine L. Cherry. A scholar is included among the top collaborators of Catherine L. Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine L. Cherry. Catherine L. Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Synnot, Anneliese, Mélanie Hawkins, Bronwen Merner, et al.. (2018). Producing an evidence‐based treatment information website in partnership with people affected by multiple sclerosis. Health Science Reports. 1(3). e24–e24. 8 indexed citations
2.
Cherry, Catherine L., Nicholas M. Murphy, Isabel Sada‐Ovalle, et al.. (2018). Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals. Frontiers in Immunology. 9. 900–900. 14 indexed citations
3.
Wadley, Antonia, et al.. (2017). Psychological Factors Associated With Painful Versus Non-Painful HIV-Associated Sensory Neuropathy. AIDS and Behavior. 22(5). 1584–1595. 19 indexed citations
4.
Cherry, Catherine L., Michael B. Black, Rachel Thomson, et al.. (2017). A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease. Immunogenetics. 69(5). 287–293. 6 indexed citations
5.
Mbenda, Huguette Gaelle Ngassa, Antonia Wadley, Zané Lombard, et al.. (2017). Genetics of HIV-associated sensory neuropathy and related pain in Africans. Journal of NeuroVirology. 23(4). 511–519. 8 indexed citations
6.
Jeremiah, Kidola, et al.. (2016). Choice of valve type and poor ventricular catheter placement: Modifiable factors associated with ventriculoperitoneal shunt failure. Journal of Clinical Neuroscience. 27. 95–98. 20 indexed citations
7.
Mills, John, et al.. (2015). Assessing Expression of MUC1 and ZAG Protein Biomarkers in Prostate Biopsies Improves Prediction of Adverse Pathology Following Radical Prostatectomy. Monash University Research Portal (Monash University). 8(1). 1–9. 1 indexed citations
8.
Wadley, Antonia, et al.. (2015). TNF Block Gene Variants Associate With Pain Intensity in Black Southern Africans With HIV-associated Sensory Neuropathy. Clinical Journal of Pain. 32(1). 45–50. 15 indexed citations
9.
Cherry, Catherine L., Antonia Wadley, & Peter Kamerman. (2012). Painful Hiv-Associated Sensory Neuropathy. Pain Management. 2(6). 543–552. 34 indexed citations
10.
Kamerman, Peter, Antonia Wadley, & Catherine L. Cherry. (2012). HIV-Associated Sensory Neuropathy: Risk Factors and Genetics. Current Pain and Headache Reports. 16(3). 226–236. 58 indexed citations
11.
Thompson, Katherine A., Catherine L. Cherry, Jeanne E. Bell, & Catriona McLean. (2011). Brain Cell Reservoirs of Latent Virus in Presymptomatic HIV-Infected Individuals. American Journal Of Pathology. 179(4). 1623–1629. 162 indexed citations
12.
Lawler, Kathy, Mosepele Mosepele, Sarah J. Ratcliffe, et al.. (2011). Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana. PLoS ONE. 6(2). e17233–e17233. 39 indexed citations
13.
Cicuttini, Flavia, et al.. (2010). The International Physical Activity Questionnaire Overestimates Moderate and Vigorous Physical Activity in HIV-Infected Individuals Compared With Accelerometry. Journal of the Association of Nurses in AIDS Care. 21(2). 173–181. 41 indexed citations
14.
Cherry, Catherine L., Alison Duncan, Kathryn Mackie, Steve Wesselingh, & Bruce J. Brew. (2008). A Report on the Effect of Commencing Enfuvirtide on Peripheral Neuropathy. AIDS Research and Human Retroviruses. 24(8). 1027–1030. 8 indexed citations
15.
Cherry, Catherine L., et al.. (2008). Cytokine Genotype Suggests a Role for Inflammation in Nucleoside Analog-Associated Sensory Neuropathy (NRTI-SN) and Predicts an Individual's NRTI-SN Risk. AIDS Research and Human Retroviruses. 24(2). 117–123. 33 indexed citations
16.
Affandi, Jacquita S., Patricia Price, Darma Imran, et al.. (2008). Can We Predict Neuropathy Risk before Stavudine Prescription in a Resource-Limited Setting?. AIDS Research and Human Retroviruses. 24(10). 1281–1284. 47 indexed citations
17.
Cherry, Catherine L., Luxshimi Lal, Katherine A. Thompson, et al.. (2005). Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.. PubMed. 38(3). 263–7. 35 indexed citations
18.
Cherry, Catherine L., David Nolan, S. Mallal, et al.. (2003). Longitudinal associations between antiretroviral treatments and quantification of tissue mitochondrial DNA from ambulatory subjects with HIV infection. Murdoch Research Repository (Murdoch University). 23. 73–5. 9 indexed citations
19.
Cherry, Catherine L.. (2003). Nucleoside analogues and HIV: the combined cost to mitochondria. Journal of Antimicrobial Chemotherapy. 51(5). 1091–1093. 20 indexed citations
20.
Gahan, Michelle E., Francis J. Miller, Sharon R. Lewin, et al.. (2001). Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction. Journal of Clinical Virology. 22(3). 241–247. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariana Gerschenson Breakdown of academic impact, for papers by Deanna Saylor Breakdown of academic impact, for papers by Tracy Fischer Breakdown of academic impact, for papers by J. E. Bell Breakdown of academic impact, for papers by Zoë Fox Breakdown of academic impact, for papers by Aylin Yilmaz Breakdown of academic impact, for papers by Michael R. Watters Breakdown of academic impact, for papers by Hong Wan Breakdown of academic impact, for papers by Katrin Hahn Breakdown of academic impact, for papers by Pasiri Sithinamsuwan
Rankless by CCL
2026